|
19.11.2024 14:33:30
|
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 19 November 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.
The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.
Please find below a statement of such trading in shares issued by Novo Nordisk.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name of the Board member/Executive/Associated Person | David Moore | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Executive Vice President, head of Corporate Development | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer | ||||
| a) | Name | Novo Nordisk A/S | |||
| b) | LEI | 549300DAQ1CVT6CXN342 | |||
| 4 | Details of the transaction(s) | ||||
| a) | Description of the financial instrument, type of instrument, | ADRs | |||
| Identification code | NVO | ||||
| b) | Nature of the transaction | Purchase of ADRs | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| DKK 709.25 | 2,500 ADRs | ||||
| d) | Aggregated information
| 2,500 ADRs DKK 1,773,118.70 | |||
| e) | Date of the transaction | 2024-11-18 | |||
| f) | Place of the transaction | New York Stock Exchange | |||
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 72,000 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.
Contacts for further information
| Media: | |
| Ambre James-Brown +45 3079 9289 abmo@novonordisk.com | Liz Skrbkova (US) +1 609 917 0632 lzsk@novonordisk.com |
| Investors: | |
| Jacob Martin Wiborg Rode +45 3075 5956 jrde@novonordisk.com | David Heiberg Landsted
+45 3077 6915 dhel@novonordisk.com |
| Sina Meyer +45 3079 6656 azey@novonordisk.com | Ida Schaap Melvold +45 3077 5649 idmg@novonordisk.com |
| Frederik Taylor Pitter +1 609 613 0568 fptr@novonordisk.com |
Company Announcement No 90 / 2024
Attachment
Nachrichten zu Novo Nordisk
|
22.11.24 |
Pluszeichen in Europa: STOXX 50 notiert im Plus (finanzen.ch) | |
|
22.11.24 |
Optimismus in Europa: So entwickelt sich der STOXX 50 am Mittag (finanzen.ch) | |
|
22.11.24 |
Freundlicher Handel: STOXX 50 beginnt Freitagshandel mit Gewinnen (finanzen.ch) | |
|
21.11.24 |
Börse Europa in Grün: STOXX 50 zeigt sich zum Ende des Donnerstagshandels fester (finanzen.ch) | |
|
21.11.24 |
Gute Stimmung in Europa: STOXX 50 am Nachmittag mit positivem Vorzeichen (finanzen.ch) | |
|
21.11.24 |
Schwache Performance in Europa: STOXX 50 im Minus (finanzen.ch) | |
|
21.11.24 |
Handel in Europa: STOXX 50 zeigt sich zum Handelsstart schwächer (finanzen.ch) | |
|
20.11.24 |
Börse Europa in Rot: STOXX 50 gibt zum Ende des Mittwochshandels nach (finanzen.ch) |
Analysen zu Novo Nordisk
| 18.11.24 | Novo Nordisk Neutral | UBS AG | |
| 15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 13.11.24 | Novo Nordisk Neutral | UBS AG | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Neutral | UBS AG |
Trump Sieg sorgt für Börsenrallye – Wall Street Live mit Tim Schäfer
Welche Aktien könnten vom Wahlsieg massgeblich profitieren? Dies Erfahren Sie in der heutigen Ausgabe von Wall Street Live.
In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| Novo Nordisk | 76.88 | 0.00% |
|
Partners Group am 21.11.2024
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
SMI geht fester ins Wochenende -- DAX beendet Handel im Plus -- US-Börsen schliessen höher -- Asiens Börsen letztlich mehrheitlich in RotDer heimische sowie der deutsche Aktienmarkt beendeten den Handel zum Wochenende mit Gewinnen. Die Börsen an der Wall Street notierten fester. Die asiatischen Börsen bewegten sich am Freitag mehrheitlich auf rotem Terrain.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |